Search

everythinglearnresearchcommunity

for

Search:↓

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

Transplanting melanocyte stem cells from hair follicles can effectively treat vitiligo.

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.

Upadacitinib effectively treats skin conditions like eczema and psoriasis and is becoming more widely used and affordable.

Nanotechnology could improve treatment for scars and atopic dermatitis by targeting skin issues more effectively.

Different types of alopecia cause hair loss due to immune system issues, with some allowing regrowth and others causing permanent loss.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

New therapies for rare skin diseases show promise but need more research.

Alopecia areata is increasing globally, with disparities needing better prevention and support.

Janus Kinase Inhibitors are promising new treatments for various skin conditions due to their effectiveness and safety.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.

Children with alopecia areata often have vitiligo, allergic asthma, ADHD, and low vitamin B12 and ferritin levels.

Alopecia areata in Taiwan has a high disease burden and needs better research and diagnostic criteria.

Understanding hair follicle signaling can improve hair disorder treatments.

Small extracellular vesicles from stem and immune cells show promise for treating various diseases but face challenges in clinical use.

Alopesi tedavisinde ilaçlar saç büyümesini teşvik eder ve yeni yaklaşımlar umut vaat eder.

Stem cell activity influences autoimmune disease outcomes by affecting immune responses and tissue regeneration.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Higher stress levels may worsen alopecia areata, suggesting stress management is important for treatment.

Calprotectin levels are higher in alopecia areata patients, indicating systemic inflammation.

Ayurvedic treatments successfully regrew hair and reduced hair loss in a woman with alopecia areata.

Mothers with alopecia areata have a higher risk of adverse birth outcomes.

Current treatments for alopecia areata can help hair grow but don't cure the disease.

An imbalanced scalp microbiome may worsen alopecia areata severity and inflammation, but treatment can partially restore balance.

Alopecia areata might help slow down certain cancers.

Alopecia areata patients have higher IgE and IL-13 levels, suggesting immune involvement.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

New insights into cell communication in psoriasis suggest innovative drug treatments.

Lichen planopilaris can occur with multiple autoimmune diseases.